Top Things to Know: Test 2024 HCM Guideline
Published: December 09, 2025
Prepared by TT Author
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Pellentesque et lectus eget ipsum bibendum scelerisque.
- Vestibulum consectetur ex vel nisl fermentum, sit amet congue enim lacinia.
- Quisque malesuada nulla at est elementum, ut scelerisque dui tristique.
- Curabitur ullamcorper augue ac lacus viverra, ac maximus augue scelerisque.
- Nulla a arcu ut felis condimentum facilisis vel et mi.
- Donec condimentum nisi sit amet tortor dignissim commodo.
- Sed rutrum sem nec pharetra dignissim.
- Vivamus ultrices nisl dapibus gravida consequat.
- Phasellus mattis leo eu maximus congue.
Citation
Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, Dearani JA, Epps-Anderson KC, Evanovich L, Ferrari VA, Joglar JA, Khan SS, Kim JJ, Kittleson MM, Krittanawong C, Martinez MW, Mital S, Naidu SS, Saberi S, Semsarian C, Times S, Waldman CB. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophiccardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee onClinical Practice Guidelines. Circulation. Published online May 8, 2024. doi: 10.1161/CIR.0000000000001250